Sophie Zucman-Caillat

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

Association analysis between HLA evolutionary divergence and CMV serological status in a cohort of 526 adult subjects.

Association analysis between HLA evolutionary divergence and CMV serological status in a cohort of 526 adult subjects.

Journal: Transplant immunology

Published: May 13, 2026

Correction: Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

Correction: Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

Journal: Bone marrow transplantation

Published: March 02, 2026

CAR T-cell expansion after idecabtagene vicleucel is a predictor of outcomes in multiple myeloma.

CAR T-cell expansion after idecabtagene vicleucel is a predictor of outcomes in multiple myeloma.

Journal: HemaSphere

Published: November 28, 2025

Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.

Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.

Journal: Research square

Published: November 24, 2025

Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of death.

Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of death.

Journal: JCI insight

Published: July 21, 2025

Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

Journal: Bone marrow transplantation

Published: June 20, 2025

Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

Journal: Bone marrow transplantation

Published: June 20, 2025

Characteristics and outcome determinants in children, adolescents and young adults who failed tisagenlecleucel for B-cell acute lymphoblastic leukemia.

Characteristics and outcome determinants in children, adolescents and young adults who failed tisagenlecleucel for B-cell acute lymphoblastic leukemia.

Journal: Leukemia

Published: June 04, 2025

Harnessing HLA Divergence for Improved Donor Selection in Haploidentical Haematopoietic Stem Cell Transplantation.

Harnessing HLA Divergence for Improved Donor Selection in Haploidentical Haematopoietic Stem Cell Transplantation.

Journal: HLA

Published: April 03, 2025

Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantation.

Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantation.

Journal: Science advances

Published: March 05, 2025

Baseline Cognitive and Neurological Status Does Not Modify the Occurrence of ICANS in CAR T-Cell Therapy for Aggressive B-Cell Lymphoma.

Baseline Cognitive and Neurological Status Does Not Modify the Occurrence of ICANS in CAR T-Cell Therapy for Aggressive B-Cell Lymphoma.

Journal: European journal of neurology

Published: January 24, 2025

Neurofilament light chain levels as an early predictive biomarker of neurotoxicity after CAR T-cell therapy.

Neurofilament light chain levels as an early predictive biomarker of neurotoxicity after CAR T-cell therapy.

Journal: Journal for immunotherapy of cancer

Published: September 08, 2024

Showing 1-12 of 82

Last Updated: 09/26/2026